These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae. Sirot D, Chanal C, Labia R, Meyran M, Sirot J, Cluzel R. J Antimicrob Chemother; 1989 Oct 01; 24(4):509-21. PubMed ID: 2693430 [Abstract] [Full Text] [Related]
15. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins. Urban C, Mariano N, Rahman N, Queenan AM, Montenegro D, Bush K, Rahal JJ. Microb Drug Resist; 2000 Oct 01; 6(4):297-303. PubMed ID: 11272258 [Abstract] [Full Text] [Related]
16. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Papanicolaou GA, Medeiros AA, Jacoby GA. Antimicrob Agents Chemother; 1990 Nov 01; 34(11):2200-9. PubMed ID: 1963529 [Abstract] [Full Text] [Related]
17. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. J Antimicrob Chemother; 1990 Nov 01; 26(5):635-48. PubMed ID: 2079446 [Abstract] [Full Text] [Related]
18. Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Nicolas MH, Jarlier V, Honore N, Philippon A, Cole ST. Antimicrob Agents Chemother; 1989 Dec 01; 33(12):2096-100. PubMed ID: 2694951 [Abstract] [Full Text] [Related]